IL1B and schizophrenia: In the group of patients with early-phase schizophrenia (up to 1 year), positive correlations were found between IL-1β and the intensity of negative symptoms (measured using the PANSS N and SANS scales) after 4-week treatment (r = 0.83 and 0.73, respectively).